Doxil (liposomal doxorubicin)
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for Doxil (liposomal doxorubicin), covering 2013-06-10 to 2014-07-21. Get the full timeline:
Most recent: Clinical Trial Update: Bortezomib, Doxorubicin Hydrochloride Liposome, and Rituximab in Treating Patients With Diffuse Large B-Cell Lymphoma That Has Relapsed or Not Responded to Treatment [Phase 2]